[pubmed] Reduced plasmablast frequency is associated with seronegative myasthenia gravis
Posté : 09 déc. 2020 12:00
Muscle Nerve. 2020 Dec 8. doi: 10.1002/mus.27140. Online ahead of print.
ABSTRACT
INTRODUCTION/AIM: The immunopathology of autoimmune seronegative myasthenia gravis (SN MG) is poorly understood. Our objective was to determine immune profiles associated with a diagnosis of SN MG.
METHODS: We performed high-dimensional flow cytometry on blood samples from SN MG patients (N=68), healthy controls (N=46), and acetylcholine receptor antibody (AChR+) MG patients (N=27). We compared 12 immune cell subsets in SN MG to controls using logistic modeling via a discovery-replication design. An exploratory analysis fit a multinomial model comparing AChR+ MG and controls to SN MG.
RESULTS: An increase in CD19+ CD20- CD38hi plasmablast frequencies was associated with lower odds of being a SN MG case in both the discovery and replication analyses (discovery p-value=0.0003, replication p-value=0.0021). IL-21 producing helper T cell frequencies were associated with a diagnosis of AChR+ MG (p=0.004).
DISCUSSION: Reduced plasmablast frequencies are strongly associated with a SN MG diagnosis and may be a useful diagnostic biomarker in the future.
PMID:33294984 | DOI:10.1002/mus.27140
Source: https://pubmed.ncbi.nlm.nih.gov/3329498 ... 9&v=2.13.0